Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05645627
What this trial is testing

Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT04566666
What this trial is testing

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Sun Pharmaceutical Industries Limited 263
Not applicableLooking for participantsNCT06030076
What this trial is testing

Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 50
Large-scale testing (Phase 3)Study completedNCT02008890
What this trial is testing

Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab

Who this might be right for
Palmoplantar Pustular Psoriasis
Novartis Pharmaceuticals 237
Large-scale testing (Phase 3)Study completedNCT03924427
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 74
Post-approval studies (Phase 4)Study completedNCT04263610
What this trial is testing

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 190
Large-scale testing (Phase 3)Study completedNCT03818035
What this trial is testing

Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 880
Testing effectiveness (Phase 2)Study completedNCT05730725
What this trial is testing

Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 109
Post-approval studies (Phase 4)Not Yet RecruitingNCT06779097
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,564
Testing effectiveness (Phase 2)Study completedNCT00001797
What this trial is testing

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00925574
What this trial is testing

The Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 71
Not applicableLooking for participantsNCT06258668
What this trial is testing

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Bristol-Myers Squibb 505
Not applicableLooking for participantsNCT07552454
What this trial is testing

Picankibart in Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Xijing Hospital 60
Large-scale testing (Phase 3)Study completedNCT04673786
What this trial is testing

Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Celltrion 509
Large-scale testing (Phase 3)Study completedNCT02660580
What this trial is testing

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsoriasisModerate to Severe Plaque Psoriasis
Fresenius Kabi SwissBioSim GmbH 443
Post-approval studies (Phase 4)Looking for participantsNCT06857942
What this trial is testing

Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Who this might be right for
PsoriasisOverweight or Obesity
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Ended earlyNCT03179605
What this trial is testing

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Who this might be right for
Psoriasis
Primus Pharmaceuticals 22
Large-scale testing (Phase 3)Study completedNCT02634801
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 162
Not applicableLooking for participantsNCT06696417
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University 1,516
Post-approval studies (Phase 4)Ended earlyNCT00972543
What this trial is testing

Raptiva in Palm and Sole Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 6
Next Page